- Home
- BBNX
as 04-17-2025 9:47am EST
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 463.4M | IPO Year: | 2025 |
| Target Price: | $26.67 | AVG Volume (30 days): | 678.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.60 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.89 - $24.50 | Next Earning Date: | 05-06-2025 |
| Revenue: | $65,123,999 | Revenue Growth: | 442.93% |
| Revenue Growth (this year): | 29.49% | Revenue Growth (next year): | 34.93% |
Latest Beta Bionics Inc. Common Stock News
BBNX Breaking Stock News: Dive into BBNX Ticker-Specific Updates for Smart Investing
GlobeNewswire
20 hours ago
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025
GlobeNewswire
8 days ago
Beta Bionics to Host Investor Event on June 22, 2025
MedTech Dive
20 days ago
Newly public Beta Bionics reports sales surge; Dexcom hires CCO
GlobeNewswire
21 days ago
Beta Bionics Announces Board Appointment of Gerard Michel
MT Newswires
23 days ago
Beta Bionics Reports Q4 Loss as Sales Rise; Sets 2025 Revenue Guidance
GlobeNewswire
23 days ago
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
Insider Monkey
a month ago
Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently
GlobeNewswire
2 months ago
Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
Compare BBNX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BBNX Beta Bionics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.